Clinical Trials in Gaziantep, Şehitkamil
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia
Primary Immune Thrombocytopenia (ITP)
Grand Shuyang Life Sciences (Chengdu) Co., Ltd.36 enrolled9 locationsNCT07233213
Recruiting
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
Muscular Ventricular Septal Defect
Occlutech International AB50 enrolled5 locationsNCT05329350
Recruiting
ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices
Heart Diseases
Occlutech International AB685 enrolled36 locationsNCT05174442